ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 118 filers reported holding ACCELERON PHARMA INC in Q1 2015. The put-call ratio across all filers is 0.99 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $724,000 | -6.9% | 17,083 | -18.2% | 0.01% | -16.7% |
| Q3 2017 | $778,000 | -16.3% | 20,883 | -31.7% | 0.01% | -14.3% |
| Q2 2017 | $929,000 | +85.4% | 30,583 | +61.3% | 0.01% | +75.0% |
| Q1 2017 | $501,000 | +4910.0% | 18,959 | +6219.7% | 0.00% | – |
| Q3 2016 | $10,000 | 0.0% | 300 | +50.0% | 0.00% | – |
| Q4 2015 | $10,000 | -94.9% | 200 | -96.2% | 0.00% | -100.0% |
| Q1 2015 | $198,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |